WASHINGTON, Feb 9- Monsanto Co will pay $80 million to settle civil accounting violations after it allegedly misstated its earnings in connection with its top-selling Roundup product, U.S. securities regulators said on Tuesday. The SEC's case against the agricultural giant revolves around a corporate rebate program designed to boost sales of Roundup, a...» Read More
The CEO of this drilling company once honestly told Cramer that the time wasn't right to buy his stock. But now he thinks it's ready.
Media companies, like the New York Times Company and News Corp, are facing a new set of challenges, and CNBC's Julia Boorstin takes an in-depth look.
This halftime report is not brought to you by (pick your prescription drug). So, we're pretty much at the midway point of big pharma's earnings season and Goldman Sachs analyst James Kelly is sizing things up so far...
There is a fondness and attraction to Cadillac, Buick and Chevrolet that is helping GM make headway in China.
A bevy of chief executives appeared on CNBC Europe Tuesday to discuss topics ranging from quarter results to the environment to what the European Central Bank should be doing.
I usually cover pharma earnings from my desk at CNBC HQ in Englewood Cliffs, NJ. But because Merck made a rare offer to interview its Chairman and CEO Dick Clark exclusively this morning I'm out at Merck's idyllic HQ campus in central NJ.
Talk about coming of age. The Beijing Auto Show and China's auto market are making a statement this week. It's loud and clear: "We are world players!" In fact, it brings up the question about whether this show and the Chinese market are bigger than the Detroit Show and U.S. Market?
Jaguar and Land Rover's Chief Executive Geoff Polites, who is credited with steering the storied British luxury brands through the ongoing sale process to India's Tata Motors, has died.
The head of Societe Generale, the French bank that recently survived the world's biggest rogue trading scandal, is relinquishing his job as chief executive but will stay on as chairman.
Daniel Bouton will give up SocGen's chief executive role after 15 years but stay on as chairman. Finance Director Frederic Oudea will take the operational helm.
Former Bear Stearns chief executive Alan "Ace" Greenberg told Reuters on Thursday he intends to stay at JPMorgan Chase after the two banks merge.
The world's biggest drug company kicked off pureplay pharma earnings season this morning with disappointing results that look to be dragging down the whole sector. PFE missed Wall Street expectations on revenue and profits.
Jack Welch, former General Electric chairman & CEO, wants to make it clear: He still supports his replacement, current CEO Jeff Immelt, despite company's worse-than-expected first quarter earnings.
Jack Welch, former General Electric chairman & CEO, took his replacement, current CEO Jeff Immelt, to task for the company's worse-than-expected first quarter earnings.
Despite world economic woes, some company executives are optimistic regarding their businesses. Here is what they told CNBC:
CEOs from around the globe have their say, from what is going on in the retail sector to how the global slowdown is effecting earnings:
I know that a number of pharma and biotech PR people read this blog, so I wanted to hold up the Genentech earnings release as what I think is a great example of user-friendliness. It is really heads and shoulders above the quarterly communications that come out of most of the companies I cover.
With the Icy Hot recall a thing of the past, Cramer says this stock’s a buy.
United Technologies on Wednesday elected Louis Chenevert chief executive, succeeding George David, who will continue as chairman of the diversified U.S. manufacturer.
United Parcel Service saw its shares fall sharply after the world's largest shipping carrier cut profit guidance, indicating more troubles for the US economy.